Particle therapy is a growing cancer treatment modality worldwide. However, there still remains a number of unanswered questions considering differences in the biological response between particles and photons. These questions, and probing of biological mechanisms in general, necessitate experimental investigation. The "Infrastructure in Proton International Research" (INSPIRE) project was created to provide an infrastructure for European research, unify research efforts on the topic of proton and ion therapy across Europe, and to facilitate the sharing of information and resources. This work highlights the radiobiological capabilities of the INSPIRE partners, providing details of physics (available particle types and energies), biology (sa...
Proton therapy is delivered to selected cancer patients presenting with rare tumours, for which a do...
Proton therapy is delivered to selected cancer patients presenting with rare tumours, for which a do...
Proton therapy is delivered to selected cancer patients presenting with rare tumours, for which a do...
Particle therapy is a growing cancer treatment modality worldwide. However, there still remains a nu...
Particle therapy is a growing cancer treatment modality worldwide. However, there still remains a nu...
Particle therapy is a growing cancer treatment modality worldwide. However, there still remains a nu...
Particle therapy is a growing cancer treatment modality worldwide. However, there still remains a nu...
Particle therapy is a growing cancer treatment modality worldwide. However, there still remains a nu...
Particle therapy is a growing cancer treatment modality worldwide. However, there still remains a nu...
Particle therapy is a growing cancer treatment modality worldwide. However, there still remains a nu...
Particle therapy is a growing cancer treatment modality worldwide. However, there still remains a nu...
Particle therapy is a growing cancer treatment modality worldwide. However, there still remains a nu...
Particle therapy using protons or heavier ions is currently the most advanced form of radiotherapy a...
Particle therapy using protons or heavier ions is currently the most advanced form of radiotherapy a...
Particle therapy using protons or heavier ions is currently the most advanced form of radiotherapy a...
Proton therapy is delivered to selected cancer patients presenting with rare tumours, for which a do...
Proton therapy is delivered to selected cancer patients presenting with rare tumours, for which a do...
Proton therapy is delivered to selected cancer patients presenting with rare tumours, for which a do...
Particle therapy is a growing cancer treatment modality worldwide. However, there still remains a nu...
Particle therapy is a growing cancer treatment modality worldwide. However, there still remains a nu...
Particle therapy is a growing cancer treatment modality worldwide. However, there still remains a nu...
Particle therapy is a growing cancer treatment modality worldwide. However, there still remains a nu...
Particle therapy is a growing cancer treatment modality worldwide. However, there still remains a nu...
Particle therapy is a growing cancer treatment modality worldwide. However, there still remains a nu...
Particle therapy is a growing cancer treatment modality worldwide. However, there still remains a nu...
Particle therapy is a growing cancer treatment modality worldwide. However, there still remains a nu...
Particle therapy is a growing cancer treatment modality worldwide. However, there still remains a nu...
Particle therapy using protons or heavier ions is currently the most advanced form of radiotherapy a...
Particle therapy using protons or heavier ions is currently the most advanced form of radiotherapy a...
Particle therapy using protons or heavier ions is currently the most advanced form of radiotherapy a...
Proton therapy is delivered to selected cancer patients presenting with rare tumours, for which a do...
Proton therapy is delivered to selected cancer patients presenting with rare tumours, for which a do...
Proton therapy is delivered to selected cancer patients presenting with rare tumours, for which a do...